(MedPage Today) — SAN ANTONIO — Risk-based breast cancer screening proved noninferior for detecting clinically significant tumors in a randomized trial, though outside experts raised concerns and a major medical group said the findings do not…
Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/119000
Author :
Publish date : 2025-12-12 22:17:00
Copyright for syndicated content belongs to the linked Source.
